Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on PTC Therapeutics (PTCT – Research Report), ...
Beta Bionics (BBNX), a maker of insulin delivery devices, has disclosed terms for an upsized $113M initial public offering.
Dermata Therapeutics (NASDAQ:DRMA) is raising ~$2.55M in a private offering priced at-the-market under Nasdaq rules. The company is offering 2,007,880 shares of its common stock (or pre-funded ...
In a report released yesterday, Joseph Schwartz from Leerink Partners maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), ...
--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that it has commenced an underwritten public offering of shares of its common stoc ...
Amesite Inc. raised approximately $3.6 million through a public offering of 1,201,667 shares ... Here are some of the largest recent moves: . (Nasdaq: AMST), a pioneering technology company ...
DETROIT, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering ... closing of its “best efforts” underwritten public offering of 1,201,667 shares of its common stock ...
in an public offering. All of the shares of common stock (and/or Pre-funded Warrants) are to be sold by the Company. Ladenburg Thalmann & Co. Inc. is acting as exclusive placement agent for the ...
Hoth Therapeutics (HOTH ... The company affirms that it has no plans for a public or private offering at this time. Hoth’s financial position remains robust, with a strong balance sheet that ...
Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener TipRanks is the ...
has successfully closed its initial public offering, selling 1.5 million ordinary shares at $4.00 each, amounting to gross proceeds of $6 million. The shares debuted on the Nasdaq Capital Market ...